- ￥2000 - 8000
- 湖北省武汉市
- Human PTPN3重组蛋白表达
- 2025年12月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称：
大肠杆菌系统重组蛋白表达
- 提供商：
普健生物（武汉）科技有限公司
Uniprot号：P26045
基因名：PTPN3
蛋白名：Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48) (Protein-tyrosine phosphatase H1) (PTP-H1)
蛋白别名：
Tyrosine-protein phosphatase non-receptor type 3, 3.1.3.48, Protein-tyrosine phosphatase H1, PTP-H1, EC:3.1.3.48
服务内容：
| 服务项目 | 客户提供 | 服务内容 | 服务周期 | 交付内容 |
|---|---|---|---|---|
| 大肠杆菌系统 蛋白表达 | 基因序列 | 方案沟通 | 1天 | 方案报告 |
| 密码子优化和基因合成 | 5天 | 基因合成报告 | ||
| 表达纯化测试 | 3天 | 表达纯化测试报告 | ||
| 1L表达及纯化 | 3天 | 蛋白样品(3-5mg)及报告 | ||
| 放大发酵及纯化 | 7天 | 纯化的蛋白及报告 |
案例展示：
PTPN3相关研究文献：
1. PTPN3 Could betae a Therapeutic Target of Pancreatic Cancer. [35641270]
2. PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor. [34134073]
3. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling. [32169891]
4. PTPN3 in cancer: unveiling its immune-mediated impact on prognosis and dysregulated signaling pathways. [38074816]
5. PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor. [31562536]
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验- An antenna-abundant glutathione S-Transferase BdGSTd8 participates in detoxification of two organophosphorus insecticides in Bactrocera dorsalis (Hendel)
- URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers
- Extracellular heme recycling and sharing across species by novel mycomembrane vesicles of a Gram-positive bacterium
- The ATR-WEE1 kinase module inhibits the MAC complex to regulate replication stress response
- A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
技术资料暂无技术资料 索取技术资料
